News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,303 Results
Type
Article (42009)
Company Profile (331)
Press Release (666963)
Section
Business (210211)
Career Advice (2083)
Deals (36599)
Drug Delivery (100)
Drug Development (82888)
Employer Resources (171)
FDA (16507)
Job Trends (15366)
News (355582)
Policy (33838)
Tag
Academia (2574)
Alliances (51253)
Alzheimer's disease (1306)
Approvals (16467)
Artificial intelligence (173)
Bankruptcy (364)
Best Places to Work (11732)
Biotechnology (213)
Breast cancer (207)
Cancer (1538)
Cardiovascular disease (127)
Career advice (1742)
CAR-T (107)
Cell therapy (312)
Clinical research (66454)
Collaboration (577)
Compensation (308)
COVID-19 (2620)
C-suite (134)
Data (1475)
Diabetes (188)
Diagnostics (6279)
Earnings (86705)
Employer resources (149)
Events (113203)
Executive appointments (482)
FDA (17285)
Funding (516)
Gene therapy (226)
GLP-1 (654)
Government (4459)
Healthcare (18920)
Infectious disease (2717)
Inflammatory bowel disease (118)
Interviews (320)
IPO (16666)
Job creations (4052)
Job search strategy (1488)
Layoffs (445)
Legal (8335)
Lung cancer (224)
Manufacturing (223)
Medical device (13316)
Medtech (13321)
Mergers & acquisitions (20180)
Metabolic disorders (508)
Neuroscience (1676)
NextGen: Class of 2025 (6631)
Non-profit (4519)
Northern California (1868)
Obesity (291)
Opinion (210)
Patents (136)
People (58588)
Phase I (20595)
Phase II (29237)
Phase III (21921)
Pipeline (613)
Postmarket research (2652)
Preclinical (8739)
Radiopharmaceuticals (244)
Rare diseases (296)
Real estate (6243)
Regulatory (22629)
Research institute (2361)
Resumes & cover letters (358)
Southern California (1613)
Startups (3715)
United States (16720)
Vaccines (596)
Weight loss (209)
Date
Last 7 days (664)
Last 30 days (1921)
Last 365 days (35347)
2025 (1585)
2024 (35806)
2023 (40634)
2022 (51798)
2021 (56329)
2020 (54794)
2019 (47401)
2018 (35771)
2017 (33141)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (210)
Asia (40257)
Australia (6439)
California (4242)
Canada (1552)
China (365)
Colorado (192)
Connecticut (204)
Europe (85700)
Florida (596)
Georgia (146)
Illinois (421)
Indiana (247)
Maryland (687)
Massachusetts (3312)
Michigan (184)
Minnesota (315)
New Jersey (1194)
New York (1203)
North Carolina (797)
Northern California (1868)
Ohio (152)
Pennsylvania (1000)
South America (1159)
Southern California (1613)
Texas (619)
Utah (120)
Washington State (434)
709,303 Results for "alexion pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo ® Technology for Neurodegenerative Disease in Research Collaboration with Alexion.
March 19, 2024
·
4 min read
Press Releases
Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo (selumetinib) for the treatment of paediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)
December 18, 2024
·
5 min read
Business
Alexion Canada Appoints Karen Heim as New General Manager
Alexion Pharma Canada Corp., AstraZeneca’s Rare Disease group, is pleased to announce the appointment of Karen Heim as Vice President and General Manager, Canada, effective April 1st, 2024.
April 2, 2024
·
3 min read
Press Releases
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
October 25, 2024
·
8 min read
Business
JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology
JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida: “JCR”) announces that it has signed a Research Collaboration, Option and License Agreement with Alexion, AstraZeneca Rare Disease (“Alexion”) for the development of novel oligonucleotide therapeutics to support targeted delivery to certain tissues or organs using J-Brain Cargo®, JCR’s proprietary blood-brain barrier (BBB)-penetrating technology.
December 21, 2023
·
5 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
January 7, 2025
·
8 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025
January 9, 2025
·
2 min read
Business
Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
Verge Genomics today announced a multi-target collaboration with Alexion, AstraZeneca Rare Disease (“Alexion”) to identify novel drug targets for rare neurodegenerative and neuromuscular diseases.
September 8, 2023
·
3 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
1 of 70,931
Next
